Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies

E Balboni, F Zagnoli, T Filippini… - Journal of Trace …, 2022 - Elsevier
Background and aim The COVID-19 pandemic has severely affected the world's population
in the last two years. Along with non-pharmacological public health interventions, major …

Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike–ACE2 interaction

SE Guimond, CJ Mycroft-West, NS Gandhi… - ACS central …, 2022 - ACS Publications
Heparan sulfate (HS) is a cell surface polysaccharide recently identified as a coreceptor with
the ACE2 protein for the S1 spike protein on SARS-CoV-2 virus, providing a tractable new …

[HTML][HTML] DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic

A Villa, E Brunialti, J Dellavedova, C Meda… - Pharmacological …, 2022 - Elsevier
All the different coronavirus SARS-CoV-2 variants isolated so far share the same
mechanism of infection mediated by the interaction of their spike (S) glycoprotein with …

Inhibiting the deubiquitinase UCHL1 reduces SARS-CoV-2 viral uptake by ACE2

JS Bednash, F Johns, D Farkas, A Elhance… - American journal of …, 2023 - atsjournals.org
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), remains a significant public health burden with limited treatment options …

[HTML][HTML] COVID-19 prophylaxis with doxycycline and zinc in health care workers: a prospective, randomized, double-blind clinical trial

N Stambouli, A Driss, F Gargouri, K Bahrini… - International Journal of …, 2022 - Elsevier
Objectives This study aims to assess the efficacy of a combination treatment of doxycycline
and zinc in the primary prevention of COVID-19 infection in Tunisian health care workers …

Preclinical evaluation of chicken egg yolk antibody (IgY) anti-RBD spike SARS-CoV-2—a candidate for passive immunization against COVID-19

H Wongso, I Mahendra, W Arnafia, I Idar, M Yusuf… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) has become a substantial threat to the
international health sector and the global economy. As of 26 December 2021, the number of …

Exploring the role of antiviral nasal sprays in the control of emerging respiratory infections in the community

C Hadjichrysanthou, AL Beukenhorst, CM Koch… - Infectious Diseases and …, 2022 - Springer
Introduction The COVID-19 pandemic has demonstrated that there is an unmet need for the
development of novel prophylactic antiviral treatments to control the outbreak of emerging …

Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future Pandemic Resilience Strategies with Strengthening Natural Immunity

SJ Wimalawansa - Heliyon, 2024 - cell.com
The original COVID-19 vaccines, developed against SARS-CoV-2, initially mitigated
hospitalizations. Bivalent vaccine boosters were used widely during 2022-23, but the …

COVID-19 in 2021

K Lundstrom, AAA Aljabali - Viruses, 2021 - mdpi.com
The Special Issue on Vaccines and Therapeutics against Coronaviruses, which was
launched in early 2021, has attracted the scientific community at large, and more than 20 …

[HTML][HTML] Проблема применения интерферонов при новой коронавирусной инфекции COVID-19 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus)

ФИ Ершов, АН Наровлянский - Вопросы вирусологии, 2022 - cyberleninka.ru
К концу 2021 г. в мире зарегистрировано около 200 исследований по изучению влияния
интерферонов (ИФН, IFN) на заболеваемость новой коронавирусной инфекцией …